Ipca Laboratories Ltd.
IPCALAB Share PricePharmaceuticals & Drugs
₹1,454.6
10.8 (0.7%)
As on December 4, 2025
Exchange Scrips: BSE524494NSEIPCALABISININE571A01038
Market Cap ₹ 36,909 Cr
P/E Ratio 50.03
Dividend Yield 0.27 %
Performance
Market performance
Open1,435
High1,470.1
Volumes8,25,619
Prev1,454.6
Low1,433
As on2025-12-04
Historical performance
1 Year High1,755.9
3 Year High1,755.9
5 Year High1,755.9
1 Year Low1,168.2
3 Year Low669.8
5 Year Low669.8
Fundamentals
Company Valuation
Market Cap (₹Cr)
36,909
Face Value (₹)
1
P/E Ratio
50.03
Dividend Yield
0.27 %
Investment Returns
1 Year
-2.3%
3 Years
67.5%
5 Years
29.2%
10 Years
276.4%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,440.28 | Bullish |
| 10-DMA | 1,428.47 | Bullish |
| 20-DMA | 1,408.28 | Bullish |
| 50-DMA | 1,351.58 | Bullish |
| 100-DMA | 1,377.15 | Bullish |
| 200-DMA | 1,388.49 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 14 | 16 | 16 | 16 | 16 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 14 | 16 | 16 | 16 | 16 |
| Public Investors | 82856 | 85566 | 88290 | 90173 | 82959 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 50.03.
- 3Y Stock Price CAGR of the stock is 19.0.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹18218 Million.
- The company generated revenue of ₹88968 Million in the previous financial year.
Ipca Laboratories Ltd.
1454.610.8 (0.7%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 974051.6
No. of Shares: 670 (Approx)
Performance:-2.6%
P/L: ₹-25948.4
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
